| Literature DB >> 27801898 |
J M Biernacka, K Sangkuhl, G Jenkins, R M Whaley, P Barman, A Batzler, R B Altman, V Arolt, J Brockmöller, C H Chen, K Domschke, D K Hall-Flavin, C J Hong, A Illi, Y Ji, O Kampman, T Kinoshita, E Leinonen, Y J Liou, T Mushiroda, S Nonen, M K Skime, L Wang, B T Baune, M Kato, Y L Liu, V Praphanphoj, J C Stingl, S J Tsai, M Kubo, T E Klein, R Weinshilboum.
Abstract
Entities:
Year: 2016 PMID: 27801898 PMCID: PMC5314112 DOI: 10.1038/tp.2016.187
Source DB: PubMed Journal: Transl Psychiatry ISSN: 2158-3188 Impact factor: 6.222
Top 10 association regions from the genome-wide association meta-analysis of the combined ISPC+AMPS sample and STAR*D (all race)
| P | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| %Change in depression score | rs35806662 | 2 | 158790425 | LOC100130766/UPP2/ACVR1 | G/A | −0.18 | −0.21 | −0.20 | 6.47E−07 |
| rs73069924 | 5 | 32278233 | MTMR12 | G/A | −0.50 | −0.42 | −0.44 | 8.09E−07 | |
| rs4615376 | 6 | 13071073 | PHACTR1 | G/A | −0.20 | −0.13 | −0.16 | 1.05E−06 | |
| rs2566255 | 11 | 4605195 | OR52I2/C11orf40 | G/C | 0.24 | 0.26 | 0.26 | 1.51E−06 | |
| rs910039 | 6 | 17505944 | CAP2 | A/G | −0.10 | −0.17 | −0.13 | 2.11E−06 | |
| rs17068112 | 6 | 139250125 | REPS1 | G/C | 0.19 | 0.37 | 0.26 | 3.28E−06 | |
| rs7485210 | 12 | 131638853 | LOC116437/LINC01257/GPR133 | A/C | 0.18 | 0.10 | 0.14 | 3.42E−06 | |
| rs74378198 | 5 | 38870908 | OSMR | G/A | −0.69 | −0.37 | −0.43 | 3.77E−06 | |
| rs10511037 | 3 | 74669078 | CNTN3 | G/A | −0.21 | −0.14 | −0.19 | 3.89E−06 | |
| rs5904601 | 23 | 22016054 | SMS/PHEX | C/T | 0.15 | 0.13 | 0.14 | 4.24E−06 | |
| Response | rs10954808 | 8 | 31479623 | NRG1 | G/A | 0.73 | 0.73 | 0.73 | 1.20E−06 |
| rs2309896 | 9 | 73959235 | TRPM3 | C/T | 0.33 | 0.43 | 0.38 | 3.26E−06 | |
| rs674246 | 11 | 113141684 | NCAM1 | C/T | 1.28 | 1.38 | 1.33 | 3.35E−06 | |
| rs72772787 | 1 | 248016378 | TRIM58 | T/C | 2.63 | 1.94 | 2.34 | 3.96E−06 | |
| rs2540651 | 22 | 18972331 | DGCR5 | A/G | 1.37 | 1.28 | 1.33 | 5.39E−06 | |
| rs7051085 | 23 | 23374977 | PTCHD1 | A/T | 0.60 | 0.69 | 0.63 | 5.51E−06 | |
| rs11018318 | 10 | 128774073 | DOCK1 | A/G | 1.30 | 1.48 | 1.38 | 6.17E−06 | |
| rs74378198 | 5 | 38870908 | OSMR | G/A | 3.96 | 2.19 | 2.40 | 7.34E−06 | |
| rs4759855 | 12 | 131640425 | LOC116437 | G/T | 0.67 | 0.67 | 0.67 | 7.47E−06 | |
| rs116842540 | 9 | 82367951 | TLE4 | T/A | 0.36 | 0.39 | 0.37 | 7.67E−06 |
Abbreviations: AMPS, Antidepressant Medication Pharmacogenomics Study; Beta/OR, regression parameter estimates (beta) for SNP effect on quantitative trait outcome or odds ratio (OR) estimate for SNP effect on binary outcome; ISPC, International SSRI Pharmacogenomics Consortium; SNP, single-nucleotide polymorphism; STAR*D, Sequenced Treatment Alternatives to Relieve Depression. There were other SNPs in these regions with suggestive evidence for association.
Note: Rather than showing results for multiple SNPs in one region, only one (top) SNP is shown for each association region.
Figure 2Manhattan plots showing genome-wide association results for the two outcome variables in the meta-analysis of ISPC, AMPS and STAR*D data. (a) %Δ depression score, (b) response. AMPS, Antidepressant Medication Pharmacogenomics Study; ISPC, International SSRI Pharmacogenomics Consortium; STAR*D, Sequenced Treatment Alternatives to Relieve Depression.